Consultant in clinical and cancer genetics
Louise Izatt has more than 20 years' experience in cancer genetics. She became consultant at Guy’s Hospital in 2002 and is the local principal investigator for many collaborative cancer genetic studies. Her PhD thesis examined the role of ataxia telangiectasia mutated gene in early onset breast cancer. She has published widely in peer-reviewed medical journals. She:
- is a medical advisor to the Ataxia Telangiectasia Society
- advised on genetics and breast cancer for the Cancer Reform Strategy at the Department of Health
- is a former member of Advisory Committee for Breast Cancer Screening in England (2009-2018)
- is a former member of the advisory group on Ionising Radiation for Human Radiosensitivity
- is a former member of Cancer Genetics steering committee (2013-9)
- is an invited member of paediatric endocrine tumour working groups (2014 onwards)
- Honorary senior lecturer in research at King’s College London, supervising a PhD research project investigating paragangliomas and phaeochromocytomas.
Education and training
- PhD in breast cancer genetics
- Cambridge University and the Royal London Hospital Medical School
- Variants of unknown significance in BRCA1
- endocrine tumours
- epidemiology of BRCA1 and BRCA2.
Tel: 020 7188 1374
- Cancer genetics
- BRCA1 and BRCA2 family service and clinic
- endocrine tumour genetics clinic
- rare cancer syndromes
- human Radiosensitivity/ DNA repair disorders including Ataxia Telangiectasia.
Last updated: November 2019